SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-007011
Filing Date
2024-01-24
Accepted
2024-01-24 16:34:11
Documents
17
Period of Report
2024-01-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20240122.htm   iXBRL 8-K 64675
2 EX-1.1 acet-ex1_1.htm EX-1.1 647006
3 EX-4.1 acet-ex4_1.htm EX-4.1 114803
4 EX-5.1 acet-ex5_1.htm EX-5.1 18822
5 EX-99.1 acet-ex99_1.htm EX-99.1 9254
6 EX-99.2 acet-ex99_2.htm EX-99.2 11674
7 GRAPHIC img94724212_0.jpg GRAPHIC 631
8 GRAPHIC img208765579_0.jpg GRAPHIC 26380
  Complete submission text file 0000950170-24-007011.txt   1168399

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20240122.xsd EX-101.SCH 25037
11 EXTRACTED XBRL INSTANCE DOCUMENT acet-20240122_htm.xml XML 4755
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 24556928
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)